Trials / Unknown
UnknownNCT05840029
VATS IN PATIENTS WITH ADVANCED OVARIAN MALIGNANCIES
THE ROLE OF VIDEO-ASSISTED THORACOSCOPIC SURGERY IN PATIENTS WITH ADVANCED OVARIAN MALIGNANCIES
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 68 (actual)
- Sponsor
- Alexandria University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 80 Years
- Healthy volunteers
- —
Summary
Ovarian cancer is the seventh most common cancer and the fifth leading cause of death in women worldwide. About 70% of patients with epithelial ovarian cancer present with advanced disease which will require a combination of cytoreductive surgery and chemotherapy to give them their best chance of long term survival.The presence of macroscopic pleural disease-especially if undetected and unresected after primary debulking surgery-may alter treatment decision-making and markedly affect survival. Video-Assisted Thoracoscopic Surgery (VATS) allows surgeons, through a minimally invasive approach, to not only drain the pleural effusion but also evaluate macroscopic pleural disease and, when possible, resect gross tumor. Few studies reported that VATS altered the therapeutic management in ovarian cancer patients leading to an upstaging or down-staging when compared to the CT staging. Therefore, this study will prospectively assess the role of VATS in the diagnosis and management of supradiaphragmatic disease as well as evaluate the impact of VATS findings on the decision of surgical management in patients with advanced ovarian cancer FIGO (The International Federation of Gynecology and Obstetrics) stage III/IV.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | VIDEO-ASSISTED THORACOSCOPIC SURGERY | A minimally invasive approach, to not only drain the pleural effusion but also evaluate macroscopic pleural disease and, when possible, resect gross tumor. |
Timeline
- Start date
- 2021-06-01
- Primary completion
- 2023-01-30
- Completion
- 2023-04-30
- First posted
- 2023-05-03
- Last updated
- 2023-05-03
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05840029. Inclusion in this directory is not an endorsement.